Insider Selling: Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Sells 3,517 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHCGet Rating) CFO Robert Thomas Freeman sold 3,517 shares of the company’s stock in a transaction on Tuesday, June 21st. The shares were sold at an average price of $12.01, for a total transaction of $42,239.17. Following the completion of the sale, the chief financial officer now owns 716,422 shares of the company’s stock, valued at approximately $8,604,228.22. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Robert Thomas Freeman also recently made the following trade(s):

  • On Friday, June 17th, Robert Thomas Freeman sold 12,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $11.18, for a total transaction of $134,160.00.
  • On Thursday, March 31st, Robert Thomas Freeman sold 4,944 shares of Alignment Healthcare stock. The stock was sold at an average price of $11.18, for a total transaction of $55,273.92.

ALHC stock traded up $0.14 during trading on Thursday, reaching $11.81. 1,431,715 shares of the company were exchanged, compared to its average volume of 630,924. The company has a market cap of $2.21 billion, a P/E ratio of -11.69 and a beta of 2.52. Alignment Healthcare, Inc. has a 52-week low of $6.14 and a 52-week high of $26.53. The stock’s 50 day moving average price is $10.36 and its 200 day moving average price is $10.27. The company has a debt-to-equity ratio of 0.52, a quick ratio of 2.90 and a current ratio of 2.90.

Alignment Healthcare (NASDAQ:ALHCGet Rating) last posted its quarterly earnings results on Thursday, May 5th. The company reported ($0.23) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.01. Alignment Healthcare had a negative net margin of 14.38% and a negative return on equity of 56.68%. The company had revenue of $345.53 million during the quarter, compared to the consensus estimate of $332.93 million. During the same period last year, the firm earned ($0.37) EPS. As a group, equities research analysts forecast that Alignment Healthcare, Inc. will post -1.09 EPS for the current year.

Institutional investors have recently bought and sold shares of the business. Nisa Investment Advisors LLC purchased a new position in shares of Alignment Healthcare in the first quarter valued at $34,000. Citigroup Inc. boosted its position in shares of Alignment Healthcare by 104.2% in the 3rd quarter. Citigroup Inc. now owns 3,002 shares of the company’s stock worth $48,000 after buying an additional 1,532 shares in the last quarter. First Quadrant LLC CA acquired a new stake in Alignment Healthcare in the 1st quarter valued at about $47,000. Zurcher Kantonalbank Zurich Cantonalbank purchased a new position in Alignment Healthcare during the 4th quarter valued at about $126,000. Finally, NewEdge Wealth LLC acquired a new position in Alignment Healthcare during the fourth quarter worth about $141,000. 82.68% of the stock is currently owned by institutional investors.

Several brokerages have issued reports on ALHC. Piper Sandler lowered their price objective on shares of Alignment Healthcare from $25.00 to $15.00 and set an “overweight” rating on the stock in a research report on Thursday, February 24th. The Goldman Sachs Group cut their price target on Alignment Healthcare from $18.00 to $16.00 and set a “buy” rating for the company in a research note on Tuesday, March 15th. Morgan Stanley cut their price target on Alignment Healthcare from $21.00 to $18.00 and set an “overweight” rating for the company in a research note on Tuesday, June 7th. Bank of America upgraded shares of Alignment Healthcare from a “neutral” rating to a “buy” rating and reduced their target price for the stock from $18.00 to $14.00 in a research note on Thursday, May 26th. Finally, William Blair reaffirmed an “outperform” rating on shares of Alignment Healthcare in a report on Thursday, May 5th. Ten equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $17.89.

Alignment Healthcare Company Profile (Get Rating)

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, and Nevada.

Recommended Stories

Insider Buying and Selling by Quarter for Alignment Healthcare (NASDAQ:ALHC)

Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.